Patent ID: 8618165

Claim:
A method for the treatment of a disease or condition chosen from peripheral insulin resistance; a diabetic condition; obesity or an overweight condition; and/or an inflammatory disease or condition; comprising administering to a human or animal patient in need thereof a pharmaceutically effective amount of a compound of formula (I) wherein R 1 and R 2 are the same or different and are chosen from a hydrogen atom, an alkyl group, a halogen atom, a hydroxy group, an alkoxy group, an acyloxy group, an acyl group, an alkenyl group, an aikynyl group, an aryl group, an alkylthio group, an alkoxycarbonyl group, an alkylsulfinyl group, an alkylsulfonyl group, an amino group, and an alkylamino group; and X represents a carboxylic acid group or a carboxylate group, or any pharmaceutically acceptable salt thereof; with the provisos that: the compound of formula (I) is not (all-Z)-4,7,10,13,16,19-docosahexaenoic acid (DHA), alpha-methyl DHA, alpha-methyl DHA methyl ester, alpha-methyl DHA ethyl ester, or alpha-hydroxy DHA ethyl ester, and R 1 and R 2 are not simultaneously a hydrogen atom.